Anti-CD9 (TSPAN29) (Motility-Related Protein-1) Monoclonal Antibody (Clone: CD9/1619)

CD9 is a type IV transmembrane glycoprotein with four transmembrane domains. CD9 on pre-B cells may play a role in cell-cell adhesion. In addition, CD9 may play a role in signal transduction mediated by interaction with low molecular weight GTP binding proteins. CD9 is expressed on early B cells, eosinophils, basophils and activated T cells and is a major component of the platelet cell surface. It is also expressed on most non-T acute lymphoblastic leukemia cells and on some acute myeloid and chronic lymphoid leukemia.

Tetraspanin-29 (TSPAN29) ; BA-2/p24 antigen; BA2; BTCC1; CD9; Cell growth-inhibiting gene 2 protein (GIG2) ; DRAP27; Leukocyte antigen MIC3; Motility-related protein (MRP1) ; p24

CD9

928

P21926

Human

Recombinant full-length human CD9 protein

CD9/1619

FACS, IHC

200 μg/mL of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/mL.

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous.

Flow Cytometry (0.5-1ug/million cells) ; Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95&degC followed by cooling at RT for 20 minutes)

Mouse IgG1, kappa